1. Home
  2. ENB vs BSX Comparison

ENB vs BSX Comparison

Compare ENB & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enbridge Inc

ENB

Enbridge Inc

HOLD

Current Price

$54.47

Market Cap

118.5B

Sector

Energy

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$69.29

Market Cap

103.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENB
BSX
Founded
1949
1979
Country
Canada
United States
Employees
14800
N/A
Industry
Natural Gas Distribution
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
118.5B
103.6B
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
ENB
BSX
Price
$54.47
$69.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
20
Target Price
$65.00
$106.85
AVG Volume (30 Days)
4.0M
10.6M
Earning Date
05-08-2026
04-22-2026
Dividend Yield
5.03%
N/A
EPS Growth
N/A
55.20
EPS
N/A
1.94
Revenue
N/A
$9,076,000,000.00
Revenue This Year
N/A
$12.02
Revenue Next Year
$3.92
$10.41
P/E Ratio
$21.67
$36.15
Revenue Growth
N/A
12.49
52 Week Low
$39.73
$67.56
52 Week High
$55.11
$109.50

Technical Indicators

Market Signals
Indicator
ENB
BSX
Relative Strength Index (RSI) 60.79 37.82
Support Level $46.65 $67.56
Resistance Level N/A $71.94
Average True Range (ATR) 0.83 1.58
MACD -0.10 0.45
Stochastic Oscillator 73.56 38.93

Price Performance

Historical Comparison
ENB
BSX

About ENB Enbridge Inc

Enbridge owns extensive midstream assets that transport hydrocarbons across the US and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also operates regulated natural gas utilities in the US and Canada, including Canada's largest natural gas distribution company. The firm has a small renewable energy portfolio primarily focused on onshore and offshore wind projects.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: